Table 5: Findings in PE-Patients.
Age |
Sex |
Death |
localisation |
Infiltrate and relevant finding |
Symptomatic |
Heparin doses (duration) |
Antiaggregation |
RHS |
D-Dimer before CT scan |
DVT |
Oncological |
Corticoid |
Obesity |
Previous VTE |
86 |
F |
Y |
Bilateral central |
Severe |
Respiratory insufficiency |
Therapeutic (16d) |
None |
|
1500-4000 |
N |
N |
Y |
N |
N |
62 |
M |
N |
Bilateral central lobar |
None |
None |
None |
None |
|
> 4000 |
N |
N |
N |
N |
N |
88 |
F |
N |
Small subsegmental |
None |
None |
None |
Apixaban |
|
|
N |
Y |
N |
Y |
N |
56 |
F |
N |
Small subsegmental |
Severe |
Dyspnoea |
Therapeutic (1d) |
None |
|
1500-4000 |
N |
N |
N |
Y |
N |
77 |
M |
Y |
Small subsegmental |
Severe |
Respiratory insufficiency |
Therapeutic (25d) |
None |
|
1500-4000 |
N |
N |
Y |
N |
N |
75 |
M |
N |
Central unilateral |
Mild |
None |
None |
Aspirin |
|
|
N |
Y |
N |
N |
N |
68 |
F |
N |
Small subsegmental |
Mild, pericardiac effusion |
Dyspnoea |
None |
None |
|
500-1500 |
N |
N |
N |
Y |
N |
55 |
F |
N |
Bilateral central |
Severe |
Respiratory insufficiency |
Therapeutic doses (2d) |
None |
|
> 4000 |
N |
N |
N |
Y |
Y |
65 |
F |
N |
Central unilateral |
Mild, emphysema |
Respiratory insufficiency |
Therapeutic (67d) |
None |
Y |
1500 -4000 |
Y |
N |
Y |
Y |
Y |